← Back to Screener
20/20 Biolabs, Inc. Common Stock (AIDX)
Price$1.71
Favorite Metrics
Price vs S&P 500 (4W)-21.47%
All Metrics
Price vs S&P 500 (YTD)-96.29%
10-Day Avg Trading Volume0.08M
3-Month Avg Trading Volume0.32M
52-Week High$50.00
Year-to-Date Return-92.54%
5-Day Price Return-3.78%
Month-to-Date Return-5.32%
Beta3.71x
52-Week Low$1.51
Industry Peers — Testing Laboratories(3)
| Symbol | P/E Ratio (Annual) | ROE (TTM) | Revenue Growth (5Y) | Indicated Dividend Yield (Annual) | Price |
|---|---|---|---|---|---|
AIDX20/20 Biolabs, Inc. Common Stock | — | — | — | — | $1.71 |
ULSUL Solutions Inc. | 56.74x | 28.77% | — | 0.58% | $92.98 |
NEONeoGenomics, Inc. | — | -12.64% | 10.35% | — | $8.23 |
BNBXBNB Plus Corp. Common Stock | — | -320.25% | 2.04% | — | $0.56 |
About
20/20 Biolabs is a commercial-stage diagnostics company developing ML-powered laboratory tests for early disease detection. The company offers two main products: OneTest for Cancer, a multi-cancer early detection blood test, and OneTest for Longevity, which measures inflammatory biomarkers. Both tests leverage real-world data to enhance diagnostic accuracy and clinical utility.